Lionco Pharmaceutical Group Co., Ltd. Class ASSE: 603669

Announcement on Postponing Disclosure of 2025 Annual Report and Report for Q1 2026

· Issued by Lionco Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Postponing Disclosure of 2025 Annual Report and Report for Q1 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment